6CM
COCH icon

683 Capital Management’s Envoy Medical COCH Stock Holding History

683 Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150,000
Closed -$1.47M – 244
2022
Q2 		$1.47M Hold
150,000
– – 0.1% 126
2022
Q1 		$1.47M Hold
150,000
– – 0.08% 147
2021
Q4 		$1.46M Buy
+150,000
New +$1.46M 0.05% 156

Other funds holding COCH

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

683 Capital Management's COCH Position: Q3 2022 in Review

683 Capital Management sold out of Envoy Medical (COCH) in Q3 2022, closing a stake of 150,000 shares — an estimated $1.47M sold.

683 Capital Management first reported a position in COCH in Q4 2021 and held it in 3 quarters. The position peaked at $1.47M in Q2 2022. 94 funds tracked by Wall St. Rank hold COCH as of Q3 2022.

  • 683 Capital Management reported no remaining Envoy Medical position as of Q3 2022 after selling out during the quarter.
  • 683 Capital Management sold 150,000 Envoy Medical shares in Q3 2022, an estimated $1.47M.
  • 683 Capital Management first reported a position in Envoy Medical in Q4 2021 and held it in 3 quarters.
  • 683 Capital Management's Envoy Medical position peaked at $1.47M in Q2 2022.
  • 94 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2022.

Based on 683 Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.